- Cannabis for Pain Management Is Employed By A Quarter of Patients With MS
- FDA Approves Buprenorphine Extended-Release Subcutaneous Injection for OUD
- Childhood Cancer Survivors Have Higher Risk of Late Surgical Interventions
- Risk Factors for Venous Thromboembolism in Kidney Transplant Recipients Identified
- More than 600 Million Affected by Low Back Pain Globally in 2020
- Robotic-Assisted Medial Knee Arthroplasty Linked to Good Long-Term Outcomes
- Bupivacaine Implant May Improve Pain Outcomes After Abdominoplasty
- Intradiscal Injection of Condoliase Looks Promising for Lumbar Disc Herniation
- Telephone Intervention Improves Care Management in Radiotherapy for HNC
- Lipid-Lowering Agents Do Not Affect COVID-19-Related Mortality Outcomes
- Medication for OUD Dispensed More After Medicare Policy Change
- Baby Boomers Push Median Age of Americans Up as Births Decline
Clinical Tools
Powered by
Powered by 
FDA Approves Brixadi, a New Treatment Option for Opioid Use Disorder
Tirofiban With Endovascular Thrombectomy Leads to Better Outcomes in LVO
RSV Vaccine Arexvy Wins FDA Approval for Older Adults
Two-Dose Hepatitis A Revaccination Schedule Optimal for Patients With HIV
Adding Cixutumumab to Paclitaxel Does Not Improve Outcomes in Esophageal/GEJ Cancer
